Literature DB >> 20347358

Heritability of premature mitral valve disease in Cavalier King Charles spaniels.

Tom Lewis1, Simon Swift, John A Woolliams, Sarah Blott.   

Abstract

Mixed model analysis of 1252 records of cardiac auscultation of 4- to 5-year-old Cavalier King Charles spaniels (CKCS) from 1991 to 2008 in conjunction with the Kennel Club pedigree records of all dogs registered from the mid 1980s to September 2007 was used to estimate variance parameters of premature mitral valve disease (MVD). Data were limited to dogs ≥4 and <5 years of age to ensure diagnostic distinction between early and late onset MVD. Cardiac murmurs were detected in 108/1252 (8.6%) dogs. Heritability estimates of 0.67 (standard error, SE 0.071) for the grade of murmur and 0.33 (SE 0.072) for the presence/absence of murmur were calculated. The variance due to clinician was 0.02 (SE 0.012) for grade and 0.03 (SE 0.017) for presence/absence of murmur. These results indicate that the presence and severity of MVD, as assessed by cardiac auscultation, in 4- to 5-year-old CKCS is highly heritable and that selection against the disease should be successful.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20347358     DOI: 10.1016/j.tvjl.2010.02.016

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  21 in total

Review 1.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

2.  Evaluation of the Swedish breeding program for cavalier King Charles spaniels.

Authors:  Tobias Lundin; Clarence Kvart
Journal:  Acta Vet Scand       Date:  2010-09-23       Impact factor: 1.695

3.  Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.

Authors:  Mara Bagardi; Sara Ghilardi; Valentina Zamarian; Fabrizio Ceciliani; Paola G Brambilla; Cristina Lecchi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

4.  Genetic evaluation of hip score in UK Labrador Retrievers.

Authors:  Thomas W Lewis; Sarah C Blott; John A Woolliams
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

5.  The challenges of pedigree dog health: approaches to combating inherited disease.

Authors:  Lindsay L Farrell; Jeffrey J Schoenebeck; Pamela Wiener; Dylan N Clements; Kim M Summers
Journal:  Canine Genet Epidemiol       Date:  2015-02-11

6.  Prevalence of disorders recorded in Cavalier King Charles Spaniels attending primary-care veterinary practices in England.

Authors:  Jennifer F Summers; Dan G O'Neill; David B Church; Peter C Thomson; Paul D McGreevy; David C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2015-04-18

7.  Preliminary genetic analyses of important musculoskeletal conditions of Thoroughbred racehorses in Hong Kong.

Authors:  Claire E Welsh; Thomas W Lewis; Sarah C Blott; Dominic J Mellor; Kenneth H Lam; Brian D Stewart; Timothy D H Parkin
Journal:  Vet J       Date:  2013-06-05       Impact factor: 2.688

8.  A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in Poland.

Authors:  Magdalena Garncarz; Marta Parzeniecka-Jaworska; Michał Jank; Magdalena Łój
Journal:  Acta Vet Scand       Date:  2013-07-11       Impact factor: 1.695

9.  Prevalence of disorders recorded in dogs attending primary-care veterinary practices in England.

Authors:  Dan G O Neill; David B Church; Paul D McGreevy; Peter C Thomson; Dave C Brodbelt
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.

Authors:  A C Birkegård; M J Reimann; T Martinussen; J Häggström; H D Pedersen; L H Olsen
Journal:  J Vet Intern Med       Date:  2015-11-17       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.